Guru Stocks at 52-Week Lows: RDS.A, PTR, UL, BP, GSK

Weekly roundup of stock prices near their historical lows

Author's Avatar
Sep 13, 2015
Article's Main Image

According to GuruFocus list of 52-week lows, these Guru stocks have reached their 52-week lows.

Royal Dutch Shell PLC (RDS.A, Financial) Reached the 52-Week Low of $50.27

The prices of Royal Dutch Shell PLC (RDS.A) shares have declined to close to the 52-week low of $50.27, which is 38.4% off the 52-week high of $79.11. Royal Dutch Shell PLC is owned by 20 Gurus we are tracking. Among them, eight have added to their positions during the past quarter. Another eight reduced their positions.

RDS.A recently reported its second quarter 2015 financial results. Royal Dutch Shell’s second quarter 2015 earnings, on a current cost of supplies basis, were $3.4 billion compared with $5.1 billion for the same quarter a year ago.

Royal Dutch Shell PLC was incorporated in England and Wales on February 5, 2002, as a private company under the Companies Act 1985, as amended. Royal Dutch Shell Plc has a market cap of $160.72 billion; its shares were traded at around $50.27 with a P/E ratio of 12.07 and P/S ratio of 0.46. The dividend yield of Royal Dutch Shell stocks is 7.48%. Royal Dutch Shell had an annual average earnings growth of 5.90% over the past five years.

PetroChina Co Ltd. (PTR, Financial) Reached the 52-Week Low of $74.43

The prices of PetroChina Co Ltd (PTR) shares have declined to close to the 52-week low of $74.43, which is 48.2% off the 52-week high of $140.97. PetroChina is owned by six Gurus we are tracking. Among them, four have added to their positions during the past quarter. Three reduced their positions.

PetroChina was established as a joint stock company on November 5, 1999. Petrochina has a market cap of $136.22 billion; its shares were traded at around $74.43 with a P/E ratio of 24.68 and P/S ratio of 0.43. The dividend yield of Petrochina stocks is 3.41%. Petrochina had an annual average earnings growth of 4.80% over the past 10 years. GuruFocus rated Petrochina the business predictability rank of 3.5-star.

Unilever PLC (UL, Financial) Reached the 52-Week Low of $39.60

The prices of Unilever PLC (UL) shares have declined to close to the 52-week low of $39.60, which is 16.1% off the 52-week high of $46.19. Unilever PLC is owned by 10 Gurus we are tracking. Among them, two have added to their positions during the past quarter. Seven reduced their positions.

Unilever has a market cap of $119.79 billion; its shares were traded at around $39.60 with a P/E ratio of 18.37 and P/S ratio of 2.07. The dividend yield of Unilever stocks is 3.37%. Unilever had an annual average earnings growth of 12.20% over the past 10 years.

BP PLC (BP, Financial) Reached the 52-Week Low of $31.01

The prices of BP PLC (BP) shares have declined to close to the 52-week low of $31.01, which is 34.9% off the 52-week high of $46.91. BP PLC is owned by 22 Gurus we are tracking. Among them, 11 have added to their positions during the past quarter. Nine reduced their positions.

BP PLC was incorporated in 1909 in England and Wales and changed its name to BP PLC. BP has a market cap of $103.4 billion; its shares were traded at around $31.01 with and P/S ratio of 0.33. The dividend yield of BP stocks is 7.73%. Bp Plc had an annual average earnings growth of 6.40% over the past five years.

BP recently reported its results for the second quarter of 2015. Underlying replacement cost profit for the quarter was $1.3 billion, compared with $2.6 billion for the previous quarter and $3.6 billion for the second quarter of 2014. The result partially reflected the impact of continued low oil and gas prices, as well as other things.

GlaxoSmithKline PLC (GSK, Financial) Reached the 52-Week Low of $40.26

The prices of GlaxoSmithKline PLC (GSK) shares have declined to close to the 52-week low of $40.26, which is 20.0% off the 52-week high of $49.08. GlaxoSmithKline PLC is owned by 27 Gurus we are tracking. Among them, 10 have added to their positions during the past quarter. Thirteen reduced their positions.

GlaxoSmithKline has a market cap of $87.41 billion; its shares were traded at around $40.26 with a P/E ratio of 6.59 and P/S ratio of 2.73. The dividend yield of GlaxoSmithKline stocks is 6.18%. GlaxoSmithKline had an annual average earnings growth of 0.30% over the past 10 years.

GSK recently reported its second quarter 2015 financial results. The company announced group sales of EUR5.9 million + 7% CER and core EPS of 17.3p (flat CER) in the first full quarter of performance since completion of the company’s transaction with Novartis. Commenting on the results, Sir Andrew Witty, CEO of GSK, stated, “Our integration and restructuring plans are on track and we remain confident that we can achieve our targets for this year and return the Group to earnings growth in 2016.”